Changes in NURR1 expression have been observed in neurodegenerative conditions such as Parkinson’s disease (PD) and Alzheimer’s disease (AD), as well as in stroke and in multiple sclerosis [10,11]. This evidence concerns the gene NR4A2 and Parkinson disease.